Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 58, 2023 - Issue 4
Submit an article Journal homepage
263
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

The usefulness of fecal hemoglobin and calprotectin tests in diagnosing significant bowel diseases: a prospective study

Min ZhuDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, ChinaView further author information
,
Liqiaona FanDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, ChinaView further author information
,
Muzhou HanDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, ChinaView further author information
,
Siying ZhuDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, ChinaView further author information
,
Shutian ZhangDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, ChinaCorrespondence[email protected]
View further author information
&
Haiyun ShiDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, ChinaCorrespondence[email protected]
View further author information
Pages 368-374 | Received 08 Sep 2022, Accepted 03 Oct 2022, Published online: 19 Oct 2022

References

  • Ford AC, Sperber AD, Corsetti M, et al. Irritable bowel syndrome. Lancet. 2020;396(10263):1675–1688.
  • Viniol A, Keunecke C, Biroga T, et al. Studies of the symptom abdominal pain–a systematic review and Meta-analysis. Fam Pract. 2014;31(5):517–529.
  • Ricciuto A, Griffiths AM. Clinical value of fecal calprotectin. Crit Rev Clin Lab Sci. 2019;56(5):307–320.
  • Caviglia GP, Ribaldone DG, Rosso C, et al. Fecal calprotectin: beyond intestinal organic diseases. Panminerva Med. 2018;60(1):29–34.
  • Vincent Z, Hornby S, Ball S, et al. Faecal calprotectin as a marker for oesophago-gastric cancer. Ann Clin Biochem. 2015;52(Pt 6):660–664.
  • An YK, Prince D, Gardiner F, et al. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and Meta-analysis. Med J Aust. 2019;211(10):461–467.
  • Ross FA, Park JH, Mansouri D, et al. The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy. Colorectal Dis. 2022;24(2):188–196.
  • Bailey SER, Abel GA, Atkins A, et al. Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England. Br J Cancer. 2021;124(7):1231–1236.
  • Randel KR, Schult AL, Botteri E, et al. Colorectal cancer screening with repeated fecal immunochemical test versus sigmoidoscopy: Baseline results from a randomized trial. Gastroenterology. 2021;160(4):1085–1096.e5. e1085.
  • van de Veerdonk W, Hoeck S, Peeters M, et al. Towards risk-stratified colorectal cancer screening. Adding risk factors to the fecal immunochemical test: Evidence, evolution and expectations. Prev Med. 2019;126:105746.
  • Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society task force on colorectal cancer. Am J Gastroenterol. 2017;112(1):37–53.
  • Schult AL, Botteri E, Hoff G, et al. Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study. BMJ Open. 2021;11(7):e048183.
  • Gupta S, Lieberman D, Anderson JC, et al. Recommendations for Follow-Up after colonoscopy and polypectomy: a consensus update by the US Multi-Society task force on colorectal cancer. Gastroenterology. 2020;158(4):1131–1153.e1135.
  • Bertani L, Mumolo MG, Tapete G, et al. Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment. Eur J Gastroenterol Hepatol. 2020;32(9):1091–1098.
  • Bhat S, Wells CI, Tan J, et al. Colonoscopy quality indicators in patients with and without prior colonic resection: a single-Centre prospective comparative study. Colorectal Dis. 2021;23(7):1755–1764.
  • Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society task force on colorectal cancer. Am J Gastroenterol. 2017;112(7):1016–1030.
  • Nakase H, Uchino M, Shinzaki S, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol. 2021;56(6):489–526.
  • Mumolo MG, Bertani L, Ceccarelli L, et al. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World J Gastroenterol. 2018;24(33):3681–3694.
  • Tibble J, Sigthorsson G, Foster R, et al. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut. 2001;49(3):402–408.
  • Limburg PJ, Devens ME, Harrington JJ, et al. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia. Am J Gastroenterol. 2003;98(10):2299–2305.
  • Meucci G, D'Incà R, Maieron R, et al. Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: a multicenter prospective study. Dig Liver Dis. 2010;42(3):191–195.
  • Turvill J, Aghahoseini A, Sivarajasingham N, et al. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study. Br J Gen Pract. 2016;66(648):e499-506–e506.
  • Widlak MM, Thomas CL, Thomas MG, et al. Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients. Aliment Pharmacol Ther. 2017;45(2):354–363.
  • Colombel JF, Shin A, Gibson PR. AGA clinical practice update on functional gastrointestinal symptoms in patients with inflammatory bowel disease: Expert review. Clin Gastroenterol Hepatol. 2019;17(3):380–390.e381.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.